Haupttitel:
The Erythropoietin Promoter Variant rs1617640 Is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin
Autor*in:
Dame, Christof; Sciesielski, Lina K.; Rau, Carolin; Badur, Chiara-Aiyleen; Bührer, Christoph
Datum der Freigabe:
2022-12-22T07:42:21Z
Abstract:
In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.
Teil des Identifiers:
e-ISSN (online): 1097-6833
Freie Schlagwörter:
rhEpo treatment
SNP risk allele
retinopathy of prematurity (ROP)
DDC-Klassifikation:
610 Medizin und Gesundheit
Publikationstyp:
Wissenschaftlicher Artikel
PubMed ID der Originalausgabe:
Zeitschrift:
The Journal of Pediatrics
Fachbereich/Einrichtung:
Charité - Universitätsmedizin Berlin
Anmerkungen:
Original article first published: 2018-05-03.
